Doxazosin oral intake therapy to relieve stent - related urinary symptoms and pain: a prospective, randomized, controlled study
Conclusions: Doxazosin Oral Intake Therapy reduced stent-related urinary symptoms, pain and the negative impact on QoL.
Source: International Braz J Urol - Category: Urology & Nephrology Source Type: research
More News: Doxazosin | Hydronephrosis | Pain | Study | Ureter and Renal Pelvis Cancer | Urology & Nephrology